High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation-Reference-Cited by-同舟云学术

High carriage rate of extended‐spectrum β‐lactamase Enterobacterales and diarrheagenic Escherichia coli in healthy donor screening for fecal microbiota transplantation

Published:2023-07-20 Issue:9 Volume:42 Page:1103-1113
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Chuang Chien,Lee Kuei-Chuan,Wang Yen-Po,Lee Pei-Chang,Chang Tien-En,Huang Yi-Hsiang,Lin Yi-Tsung^ORCID,Hou Ming-Chih

Funder

Taipei Veterans General Hospital

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04644-3.pdf

Reference34 articles.

1. Hvas CL, Dahl Jørgensen SM, Jørgensen SP et al (2019) Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection. Gastroenterology 156:1324–32.e3

2. van Prehn J, Reigadas E, Vogelzang EH et al (2021) European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27(Suppl 2):S1–S21

3. Bakken JS, Borody T, Brandt LJ et al (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9(12):1044–9

4. DeFilipp Z, Bloom PP, Torres Soto M et al (2019) Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N Engl J Med 381:2043–2050

5. Zellmer C, Sater MRA, Huntley MH et al (2021) Shiga toxin-producing E. coli transmission via fecal microbiota transplant. Clin Infect Dis 72:e876–e880

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches;International Journal of Molecular Sciences;2024-09-08

2. The Potential Harmful Effects of Genetically Engineered Microorganisms (GEMs) on the Intestinal Microbiome and Public Health;Microorganisms;2024-01-23

3. Clostridioides difficile infection: a changing treatment paradigm;Gastroenterology Review;2024

4. Assuring safety of fecal microbiota transplantation in the COVID‐19 era: A single‐center experience;JGH Open;2023-10-20